Failure of rechallenge clozapine after agranulocytosis: A case report
Source | ENCEPHALE (n°5 vol 45) |
Auteur(s) : | ROMEO B, Aut. ; PETILLION A, Aut. ; MARTELLI C, Aut. ; BENYAMINA A, Aut. |
Année de publication : | 2019 |
Pages : | 449-450 |
Mots-clés : | CLOZAPINE ; CAS CLINIQUE ; EFFET SECONDAIRE ; SCHIZOPHRENIE RESISTANTE ; |
Résumé : | Clozapine is the standard treatment for resistant schizophrenia [1]. However, clozapine can cause side effects including heamatological side effects [2]. Given the clear benefit of clozapine use in patients with resistant schizophrenia, the reintroduction of this treatment after a side effect needs to be studied |